AGEN
Agenus Inc.
Company Overview
| Mkt Cap | $128.73M | Price | $3.97 |
| Volume | 469.32K | Change | +4.20% |
| P/E Ratio | -0.6 | Open | $3.99 |
| Revenue | $103.5M | Prev Close | $3.81 |
| Net Income | $-227.2M | 52W Range | $1.38 - $7.34 |
| Div Yield | N/A | Target | $12.33 |
| Overall | 37 | Value | 40 |
| Quality | 36 | Technical | 36 |
No chart data available
Stock Overview
Updated DailyAgenus Inc. (AGEN) is a leading Healthcare company in the Biotechnology industry, currently trading at $3.97 with a market capitalization of $128.73 million. The stock is trading in the middle of its 52-week range, demonstrating concerning quality fundamentals with a MarketXLS quality score of 36.
Today's trading session shows AGEN with a volume of 469K shares. The stock opened up 4.72% from yesterday's close of $3.81. Current analyst estimates project earnings of $0.6 per share for this year, with next year targeting $-2.26.
AGEN demonstrates concerning technical signals based on technical analysis. The company trades on the NSC exchange and operates alongside industry peers including IDRA, NWBO, MRK, PARD, GSK.
Key investment considerations for AGEN include concerning overall investment profile. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 210.6%. The stock shows elevated valuation levels based on valuation analysis.
Analysis generated on November 3, 2025 at 01:56 PM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | AGEN | $3.97 | +4.2% | 469.32K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |